Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

Tekla Healthcare Investors  as of 08/31/2015

NYSE / HQH Asset Class:  Sector Equity Funds 1 YR Lipper Avg:  -3.56%

Growth of $10K

Avg Annual Total Return %
  10 YR 5 YR 1 YR YTD
Market Return 14.47% 34.89% 26.11% 11.27%
Lipper Pct. Rank 25 19 20 24
NAV Return 13.50% 29.87% 21.82% 11.45%
Lipper Pct. Rank 25 19 14 17
Premium/Discount History

10 YR Avg 5 YR Avg YTD Avg
-7.738% -4.797% 2.490%

NAV $33.12 Market Price $33.01
Net Change -$0.86 Market Change -$0.92
Premium/Discount -0.33%
1 YR NAV Return 21.821%
1 YR NAV Rank 14
12-Mo Yield as of 7/31/2015 Yield Def
Income Only Yield 0.00%
Distribution Yield (Market) 6.71%
Managed Distribution Plan 
Most Recent Income Dividend $0.680
Ex-Div Date 5/22/2015
Most Recent Cap Gain Dividend $0.530
Ex-Div Date 2/27/2014
Dividend Frequency Quarterly
YTD Dividends $1.310
YTD Capital Gains --
Inception Date 4/23/1987
Fund Advisor Tekla Capital Management LLC
Manager & Tenure Team Managed
Phone 800-451-2597
Total Net Assets (mil) as of 7/31/2015 $1,346.4
% Leveraged Assets as of 9/30/2014 --
Portfolio Turnover --
Mgmt Fees 0.960%
Expense Ratio 1.130%
Fund Objective
The Fund seeks long-term capital appreciation by investing primarily in securities of companies in the health services and medical technology (health care) industries ("Health care Companies").
Top Holdings (as of 3/31/2015)
Celgene Corp ORD 9.26%
Gilead Sciences Inc ORD 7.91%
Allergan plc ORD 6.08%
Biogen Inc ORD 5.58%
Regeneron Pharmaceuticals Inc ORD 4.84%
Alexion Pharmaceuticals Inc ORD 4.17%
Biomarin Pharmaceutical Inc ORD 4.10%
Incyte Corp ORD 3.77%
Amgen Inc ORD 3.16%
Vertex Pharmaceuticals Inc ORD 3.11%
Top Sectors (as of 3/31/2015)
Health Care 84.37%
Non Classified Equity 6.63%
Technology 1.97%
Consumer Services 1.24%

Image Map


Aberdeen Closed-End TV

CEF Connect


National Association of
Publicly Traded Partnerships


Seeking Alpha CEF Articles
SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

© Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.